🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Gene-replacement therapy means some children who once would have died at an early age or required a gruelling stem cell transplant are now having typical life experiences, such as attending school and living at home with their families x.com/i/events/15302…

The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence. trib.al/Erh2G5F

Like my son, who just turned 11, Samuel Habib has a #GNAO1 disorder. Our families are part of a global alliance of patient family orgs supporting each other + research to find a cure. Ale is navigating the journey to adulthood with little guidance, so 🙏 Samuel & @_danhabib.

#GNAO1 International Research Updates, Jun 6, 2022 10am-1:30pm EDT, 4pm-7:30pm CEST Moderator: K Martemyanov Kirill Martemyanov Lab Speakers: F Baas/H Mikkers (NL) S Martinelli (IT) V Katanaev (CH) J Valnohova (CH) I Shomer (IL) X Chen (US) M Sena-Esteves (US) R Neubig Rick Neubig (US)

Genetic Landscape of Childhood-Onset Hyperkinetic Movement Disorders from Prof Kurian et al. #neurotwitter Parkinsonism-dystonia : DDC, DHPR, PTPS, SLC6A3, SPR, TH Chorea: ADCY5, ATP1A3, FOXG1, NKX2.1, SLC2A1, GNAO1, PDE10A Stereotypies: FOXG1, GNAO1 doi.org/10.1002/mds.29…

GM is a grinder’s mindset. While you’re participating in Blur’s 48th airdrop challenge, I’m making sure I’ll dance with my daughter one day.

Data hot off the presses! We performed a screen to assess the activation of a GPCR signaling pathway in a GNAO1/GPA1 yeast avatar with reduced pathway activity at baseline. Hit 1 (left) versus untreated control (right)

Tres años de sonrisas y lágrimas, ilusión y desilusiones,pero sobre todo tres años de esperanza🤞🤞🤞. Gracias por acompañarnos en este viaje! #GNAO1 #EERR #FebreroRaro

🚨🚨🚨Funding Opportunity! The Bow Foundation & The Orphan Disease Center @ UPenn are seeking #grant applications to support research related to #GNAO1 Neurodevelopmental Disorder. LOIs are due March 3, 2023; APPLY TODAY!! Follow the link to learn more: ow.ly/zLRs50MMxu2 #RareDisease #rare

GNAO1 yeast avatars update: The G203R variant (left) acts as both gain-of-function and loss-of-function. The G204A variant (right) behaves like a classic loss-of-function. GNAO1 Action

Today’s FDA approval of our new treatment for Duchenne muscular dystrophy represents an important moment for Sarepta and the Duchenne community. Watch to hear a message from our CEO, Doug Ingram:

Happy to share that our multidisciplinary team from 10 countries (IT, CH, DE, FR, IL, TR; ES, NL, HR, UK) has been awarded >1.6M€ for a #GNAO1 natural history study under the @EJPRareDiseases Joint Transnational Call 2023. Our aim is to enrol 90 patients ages 0-18 over 3 years.

On our project team: Istituto Neurologico Carlo Besta, Hospital Sant Joan de Déu Barcelona ES, Université de Genève, Fondazione Santa Lucia, Sheba Medical Center, CHU de Montpellier, Uniklinik Köln, Gazi Üniversitesi, Ricerca Sapienza, Bambino Gesù, Amsterdam Neuroscience | Amsterdam UMC, UHC Sestre Milosrdnice, Evelina London Famiglie GNAO1, GNAO1 España, Stichting GNAO1 NL

We're tracking over 60 companies actively actively engaged in the development of #quantum computers

See the abstract + partners of our winning project for @EJPRareDiseases Joint Transnational Call 2023: #GNAO1-EU: European Natural History Study* and search for novel biomarkers in GNAO1-associated disorders. ejprarediseases.org/gnao1-eu/ *including setup of an international registry

Reminder — 2025 Famiglie GNAO1 grant deadline Wed, 30 April Potential areas of the #GNAO1 study: • Genetic/molecular studies • Development of therapies • Pre-clinical/clinical trials Eligibility and details: gnao1.it/research-grant…

-1 month to the 2025 GNAO European Conference (20-21 June) at Univ. of Cologne, Germany Speakers from CA, CH, CN, DE, ES, IT, KR, NL, US Day 1: Basic science, preclinical & clinical research Day 2: Clinical & caregiver aspects Program + registration @ gnao1.aey-congresse.de/start/program.….